Glucose
Health, Inc. – New 2-Pack GLUCODOWN® Raspberry # 1 at
Amazon
BENTONVILLE, AR --
January 25, 2021 -- InvestorsHub NewsWire
-- New GLUCODOWN® 2-Pack
Raspberry arrived at Amazon last week – and is already
trending
across Amazon.com
as a
# 1 New Release.
Amazon
affixes the # 1 New Release moniker to new
products
which are showing strong
consumer
interest in their category.
From the time
GLUCODOWN®
first
listed
at
Amazon in
late 2018, unauthorized
third-party sellers have
enjoyed
success re-selling
GLUCODOWN®. Previously,
on
January 4, 2021,
Glucose
Health, Inc. (OTC:
GLUC) ("Company") advised shareholders the Company
intended
re-capture the revenue
now
benefitting
third-party
sellers, by
listing
its
own
variety
and double
packs
for
sale at
Amazon.
In just
three weeks, all flavors of GLUCODOWN® now have active 2-Pack
listings available for sale on Amazon.
Amazon Inventory
Restrictions
In response to
burgeoning demand by consumers for online shopping, accelerated by
the pandemic, Amazon imposed limits on shipments
of
inventory to its
fulfillment
centers from
its
seller partners, including Glucose
Health, Inc. The
restrictions
significantly
reduced both the size and
frequency of shipments
to
Amazon to
satisfy
orders for
GLUCODOWN®. The Company
immediately
appealed
to
Amazon, making
the
case the
restrictions would
inevitably result in
GLUCODOWN®
selling-out
in
just
weeks.
Following
GLUCODOWN® Lemon
and then Raspberry selling out and
an
urgent
appeal to
Amazon's leadership team, the
Company's
inventory
allotment at Amazon
was
substantially increased. 5,000+ containers
have
already shipped from
the Company's Rogers,
Arkansas logistics partner and
are at
various stages of receiving in Amazon's inventory
system. Additionally,
replenishment
shipments to Amazon are now proceeding
relatively
normally
– a shipment of more than
1,000 containers is
being
readied for picked up by
Amazon later
this
week.
Despite
many
GLUCODOWN®
items
in
sold-out
status
this
month, the Company is
advising shareholders that January 2021
Amazon
revenues, nevertheless,
have
already
reached
$30,000
–
a
133%
increase over January 2020
revenues of $12,827
–
with 7
selling days still
remaining
in this
month.
Additionally,
in
response to Amazon's
inventory
restrictions, the
Company
greatly
accelerated
implementation
of its e-commerce plans
for glucodown.com, first
announced
on January 4,
2021. The Company
is
pleased to advise
its
merchant
account and credit card, debit card and e-check payment processing
gateways all
went live
this past Friday, January
22. For the first
time, all
GLUCODOWN® flavors
are
available
for purchase
directly
from Glucose Health,
Inc. Despite no
prior
announcement or
advertising, multiple
orders for
GLUCODOWN® have
already been processed
through glucodown.com
this last
weekend.
Website
orders will be
fulfilled via our Rogers,
Arkansas logistics
partner.
About Glucose Health, Inc. (OTC:
GLUC)
More than 100 million
Americans are estimated to be diabetic or pre-diabetic, by the
Centers for Disease Control and Prevention.2
Introduced
in
2018 and manufactured by
Glucose Health, Inc., the
GLUCODOWN®
brand
has
come
to define an entirely
new and distinct dietary supplement
category – functional,
diabetic
friendly,
beverages. By specializing in
producing delicious and
efficacious beverages
nutritionally
appropriate1
for the
nation's 100+ million pre and Type-2 diabetics, GLUCODOWN® is
uniquely and strongly positioned among all up & coming beverage
companies in America. Glucose Health, Inc.
is a publicly traded company with the ticker symbol OTC:
GLUC.
For
more
GLUC news visit
www.glucosehealthinc.com
Like us on Facebook at
www.facebook.com/glucodown
1 For
citations visit www.glucodown.com/clinical-data
2
National Diabetes Statistics Review, 2020;
Centers for Disease Control and Prevention, Department of Health
and Human Services.
This
news
release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and
while
Glucose
Health, Inc. is not subject to the 1934 Securities and Exchange
Act, contains
forward-looking statements within the meaning Section 21E of the
Securities and Exchange Act of 1934, as amended. Statements that
are not a description of historical facts constitute
forward-looking statements and may often, but not always, be
identified by the use of such words as "expects," "anticipates,"
"intends," "estimates," "plans," "potential, "possible," "probable,
"believes," "seeks," "may, "will, "should," "could" or the negative
of such terms or other similar expressions. Actual results may
differ materially from those set forth in this release due to the
risks and uncertainties inherent in the Company's business. Readers
are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof. All
forward-looking statements are qualified in their entirety by this
cautionary statement and the Company undertakes no obligation to
revise or update this release to reflect events or circumstances
after the date hereof.
Contact:
Murray
Fleming
Glucose Health,
Inc.
info@glucosehealthinc.com
(479)
802-3827